3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol has been researched along with sk&f 82958 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, K; Cools, AR; Kobayashi, M; Koshikawa, N; Miwa, Y | 1 |
| Ikeda, K; Ikejiri, M; Kiyoshi, A; Kotani, M; Matsumoto, A; Matsumoto, K; Murai, T; Nakako, T; Ogi, Y | 1 |
2 other study(ies) available for 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and sk&f 82958
| Article | Year |
|---|---|
Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
Topics: Animals; Behavior, Animal; Benzazepines; Benzopyrans; Domperidone; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Jaw; Male; Movement; Nucleus Accumbens; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tetrahydronaphthalenes | 1996 |
The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
Topics: Acetamides; Animals; Apomorphine; Benzamides; Benzazepines; Benzopyrans; Blinking; Callithrix; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Hypnotics and Sedatives; Male; Models, Animal; Oxazines; Piperazines; Pyridines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4 | 2016 |